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1015-9584/Copyright ª 2014, Asian SuSummary Objective: Little information is available on the relationship between hospital vol-
ume and the outcomes of laparoscopic gastrectomy for gastric cancer in patients with comor-
bidity. This study aimed to investigate the influence of hospital volume on patient outcomes of
laparoscopic gastrectomy for gastric cancer in patients with comorbidity using a national
administrative database.
Methods: A total of 5941 comorbid patients treated with laparoscopic gastrectomy for gastric
cancer were referred to 741 hospitals in Japan. We collected patients’ data from the admin-
istrative database to compare laparoscopy-related complications, in-hospital mortality, length
of stay (LOS), and medical costs during hospitalization in relation to hospital volume. Hospital
volume was categorized into two groups: low (<40 cases in 3 years; n Z 4111) and high (40
cases; n Z 1830).
Results: There were no significant differences between the groups in laparoscopy-related com-
plications and in-hospital mortality (pZ 0.684 and pZ 0.200, respectively). However, signif-
icant variations in mean LOS and medical costs were observed between hospital volume
categories (26.1 days vs. 20.2 days and 16,163.9 US dollars vs. 14,345.9 US dollars, respec-
tively; p < 0.001). Multiple linear regressions revealed that higher hospital volume was signif-
icantly associated with shorter LOS and lower medical costs during hospitalization. The
unstandardized coefficient for LOS was 4.62 days (95% confidence interval Z 5.63e
3.60, p < 0.001), whereas that for medical costs was 1424.1 US dollars (95% confidence
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reserved.1. Introduction
Gastric cancer is one of the leading causes of cancer death
in the world.1,2 According to the vital statistics released by
the Ministry of Health, Welfare, and Labour in Japan,
approximately 50,000 Japanese people die from gastric
cancer annually, representing approximately 15% of annual
cancer-related deaths over the past 4 decades.3 Recently,
endoscopic resection, such as endoscopic mucosal resec-
tion or endoscopic submucosal dissection, has been
frequently performed because of the early detection or
diagnosis of gastric cancer.4 However, the number of sur-
gical resections for gastric cancer remains high in Japan.5
Recent advances in surgical techniques have enabled
more effective and safe operations for gastric cancer.
Laparoscopic gastrectomy is a less-invasive operation for
gastric cancer compared with open gastrectomy, and some
previous reports suggest that laparoscopic gastrectomy can
be performed safely with lower morbidity and mortality.6e8
In addition, this procedure has a favorable effect with re-
gard to the length of hospitalization and the medical costs
of patients.9,10 Currently, laparoscopic gastrectomy is a
widely accepted procedure for treating gastric cancer, and
the number of patients undergoing laparoscopic gastrec-
tomy has been increasing in Japan.11
Since Luft et al12 reported a correlation between hos-
pital volume and patient outcomes, health policy measures
advocating high hospital volume have been predicated on
the overwhelming empirical evidence of the hospital vol-
umeeoutcome relationship. Many studies, especially over
the past decade, have shown significant associations be-
tween the volume of hospital services provided and patient
outcomes, particularly for a wide variety of surgical pro-
cedures.13,14 Although the reasons for such relationships
have not been fully explained, these results suggest that
hospital volume is a significant independent indicator of
patient outcome.
However, little information is available on the relation-
ship between hospital volume and patient outcomes of
laparoscopic gastrectomy for gastric cancer. In addition,
there have been no reports that have focused on the vol-
ume effect for outcomes of patients with comorbidity.
Clarification of the relationship between hospital volume
and the outcomes of laparoscopic gastrectomy in patients
with comorbidity could contribute to studies of the quality
of patient medical care, which could in turn have signifi-
cant implications for health care policy decision making.
In this study, we investigated the influence of hospital
volume on outcomes of laparoscopic gastrectomy for
gastric cancer in patients with comorbidity. This was ach-
ieved using the national administrative database developed
in the Japanese case-mix system project named the Diag-
nosis Procedure Combination (DPC) system, which is aunique insurance reimbursement scheme for incentive
payments.
2. Materials and methods
2.1. DPC system and database
The health care system of Japan has severe financial
problems because of the expense of new medical tech-
nology, a rapidly aging society, and extended patient hos-
pitalizations.15,16 To address these issues, the Ministry of
Health, Labour, and Welfare and its affiliated research
institute have begun investigating whether the Japanese
case-mix classification system can be used to standardize
medical profiling and payment.13e16 As a result, Japanese
case-mix projects based on the DPC system were intro-
duced to 82 academic hospitals (National Cancer Center,
National Cardiovascular Center, and 80 university hospi-
tals) in 2003.13e16 Reimbursement from health insurance
using the DPC system is common practice in Japan. Ac-
cording to the administrative database of the DPC system,
the number of acute care hospitals has increased. Enor-
mous amounts of inpatient data have been collected
annually, covering approximately 90% of the total acute
care inpatient hospitalizations.13e16
Each patient’s financial data, claim information, and
discharge summary, which includes principal diagnosis,
comorbidity at the time of admission, and complications
during hospitalization, are recorded in the administrative
database of the DPC system. These data are coded using
the International Classification of Diseases and Injuries,10th
Revision (ICD-10) code. Additionally, this administrative
database also contains comprehensive medical informa-
tion, including all interventional or surgical procedures,
medications, and devices that have been indexed in the
original Japanese code. The Ministry of Health, Labour, and
Welfare of Japan assigns these codes.13e16 The date and
amount of care delivered each day are also recorded in the
DPC administrative database.13e16
2.2. Study setting
We selected 12,522 patients treated with laparoscopic
gastrectomy for gastric cancer at 741 DPC participation
hospitals (83 academic and 658 community hospitals) be-
tween 2009 and 2011 in Japan. The hospitals involved are
dispersed throughout Japan and play leading roles in
providing acute care medicine, advancing medical
research, and educating students and medical residents.
We calculated the number of laparoscopic gastrectomies
performed for gastric cancer in each hospital, and hospital
volume was expressed as the number of cases during the
Hospital volume and laparoscopic gastrectomy 35study period, and was initially evaluated as a continuous
variable. However, categorical variables defining two cat-
egories of hospital volume were created to simplify the
presentation of the results in this study: low-volume hos-
pitals (LVHs) had < 40 cases (n Z 8561) and high-volume
hospitals (HVHs) had 40 cases during the study period
(n Z 3961). These categories were based on cutoff values
that yielded roughly equivalent numbers of patients in each
volume category. This method has frequently been used in
previous studies of hospital volume.13,14,16
In addition, we analyzed the Charlson Comorbidity Index
(CCI) score for each patient using the data of the ICD-10
codes in the administrative database. The CCI score was
expressed as the score of all comorbid conditions, and it
was initially evaluated as a continuous variable.15,16 We
excluded 6581 patients whose CCI scores were zero (4450
patients at LVHs and 2131 patients at HVHs). This left 5941
comorbid patients treated with laparoscopic gastrectomy
for gastric cancer allocated for analysis (4111 patients at
LVHs and 1830 patients at HVHs; Fig. 1).
The use of DPC data was permitted by all institutions and
hospitals that provided detailed data. The research proto-
col of the study was approved by the Ethics Committee of
Medical Care and Research of the University of Occupa-
tional and Environmental Health, Kitakyushu, Japan.2.3. Study variables
We collected data in the administrative database with re-
gard to the characteristics of patients and hospitals as
follows: levels of comorbidity, age, sex, location of gastric
cancer, kinds of gastrectomy, hospital type, size, and re-
gion, laparoscopy-related complications, in-hospital mor-
tality, length of stay (LOS), and medical costs during
hospitalization.
Levels of comorbidity (by CCI score) defining three
categories of severity were created to simplify theFigure 1 Patient selection and classificapresentation of the results: 1, mild; 2, moderate; and 3,
severe.16 Furthermore, chronic comorbid conditions were
classified according to each representative organ system:
hypertension (I10eI15), diabetes mellitus (E10eE14), pul-
monary diseases (J00eJ99), ischemic heart diseases
(I20eI25), cerebrovascular diseases (I60eI69), liver
cirrhosis (K70eK74), and renal failure (N17eN19).17 Age
categories were stratified as follows: < 60 years, 60e69
years, 70e79 years, and 80 years. Location of cancer was
defined by the ICD-10 codes: C16.0 (cardia); C16.1
(fundus); C16.2 (body); C16.3 (antrum); C16.4 (pylorus);
and C16.5, C16.6, C16.8, and C16.9 (unknown category).
The Japanese Classification of Gastric Cancer describes
tumor locations anatomically in three divisions, namely,
upper, middle, or lower third.18 Therefore, the locations of
gastric cancer were divided into three anatomical posi-
tions: upper (cardia and fundus), middle (body), and lower
third (antrum and pylorus) as described in the previously
published medical literature.18,19 Hospital type was clas-
sified as academic or community. Hospital size was cate-
gorized into three groups according to the number of
hospital beds: small (< 200 beds), medium (200e600
beds), and large (>600 beds). Hospital region was also
divided into two categories: urban and rural. We defined
an urban region as a prefecture that has a degree of
population concentration of 50%, and a rural region as a
prefecture that has a degree of population concentration
< 50%, as reported previously.20 Laparoscopy-related
complications included wound complications such as
infection or dehiscence, anastomosis leakage, intra-
abdominal hematoma, or others (T80e87), bowel
obstruction (K56.5e56.7, K65.0, K65.8e9, K66.0, and
K91.3), peritonitis (K56.0, K56.2), and acute pancreatitis
(K85). These laparoscopy-related complications were
defined according to published criteria.9,10 For the analysis
of medical costs during hospitalization, we assumed the
yen to dollar exchange rate to be approximately 100 yen to
the US dollar (June 2013).tion from the administrative database.
Table 1 Characteristics of patients and hospitals ac-
cording to hospital volume.
LVHs HVHs p
(n Z
4111)
(n Z
1830)
Patient characteristics
Comorbidity (%)
Mild (CCI Z 1) 56.3 58.9 0.087
Moderate (CCI Z 2) 22.6 22.4
Severe (CCI  3) 21.1 18.7
Organ system (%)
Hypertension 29.7 27.6 0.096
Diabetes mellitus 28.2 25.0 0.011
Pulmonary diseases 15.6 12.9 0.006
Ischemic heart
diseases
12.3 11.1 0.194
Cerebrovascular
diseases
8.4 8.2 0.832
Liver cirrhosis 3.2 2.7 0.310
Renal failure 2.0 2.3 0.414
Age categories (%)
<60 y 15.5 16.4 <0.001
60e69 y 26.7 29.2
70e79 y 35.8 37.1
80 y 22.0 17.3
Sex (%)
36 A. Murata et al.2.4. Statistical analysis
For tests of statistical significance, we used the c2 test for
categorical data, and the ManneWhitney U test for
continuous variables. We used logistic regression models to
estimate the odds ratios (ORs) and their 95% confidence
intervals (CIs) for laparoscopy-related complications and in-
hospital mortality, with the LVH group as the reference
group. Linear regression models were also used to identify
the influence of hospital volume on LOS and medical costs
during hospitalization. To control for selection bias with
regard to baseline characteristics of patients between
groups, we performed generalized propensity score analysis
to estimate the doseeresponse function for patient groups.
The propensity score method has been widely used in
observational studies to deal with possible biases that in-
fluence the effect of hospital volume.21,22 We used a
multinomial logistic regression model with logit as the link
function to obtain generalized propensity scores using the
data of patient characteristics such as levels of comorbid-
ity, age, sex, location of gastric cancer, and type of gas-
trectomy. Multiple logistic and linear regression models
were used to identify the influence of hospital volume,
considering propensity scores and hospital characteristics.
All statistical analyses were performed using STATA
version 11.0 statistical software (Stata Corporation, College
Station, TX, USA). A value of p < 0.05 was considered
significant.Male 72.8 72.3 0.713
Female 27.2 27.7
Location of cancer (%)
Upper 4.3 5.4 <0.001
Middle 39.6 46.5
Lower 39.4 37.3
Unknown 16.7 10.8
Type of gastrectomy (%)
Total 5.5 11.6 <0.001
Partial 94.5 88.4
Hospital characteristics
Hospital type (%)
Academic 7.7 21.2 <0.001
Community 92.3 78.8
Hospital size (%)
Small 32.9 17.9 <0.001
Medium 53.8 36.7
Large 13.3 45.4
Hospital region (%)
Urban 45.5 60.8 <0.001
Rural 54.5 39.2
Patient outcomes
Laparoscopy
complications (%)
9.3 9.0 0.684
In-hospital
mortality (%)
0.5 0.3 0.200
Mean length of
stay (d)
26.1 20.2 <0.001
Mean medical costs
(US dollars)
16,163.9 14,345.9 <0.001
CCI Z Charlson Comorbidity Index; HVH Z high-volume
hospital; LVH Z low-volume hospital.3. Results
Characteristics of patients and hospitals are shown in
Table 1. Although the ratio of severity of comorbid condi-
tions was similar between hospital volumes, that of pa-
tients with diabetes mellitus or pulmonary diseases was
significantly higher in LVHs. HVHs performed more total
gastrectomies for gastric cancer than did LVHs (11.6% vs.
5.5%; p < 0.001). The rate of gastrectomy performed in
urban regions was significantly higher in HVHs (p < 0.001).
No significant difference was seen in the laparoscopy-
related complications and in-hospital mortality between
groups (9.3% vs. 9.0% and 0.3% vs. 0.5%; p Z 0.684 and
pZ 0.200, respectively). However, significant variations in
mean LOS and medical costs during hospitalization were
observed between hospital volume categories (p < 0.001).
Additionally, large hospitals had shorter LOS compared with
small or medium-sized hospitals (21.6 days vs. 25.8 days vs.
24.6 days; p < 0.001 and data not shown, respectively).
The logistic regression analyses for laparoscopy-related
complications and in-hospital mortality are shown in Table
2. Simple logistic regression revealed that hospital volume
was not significantly associated with decreased relative risk
of laparoscopy-related complications. The OR of HVHs was
0.96 (p Z 0.684). After adjustment for patient character-
istics as well as hospital characteristics, no significant as-
sociation was seen between the occurrence of laparoscopy-
related complications and hospital volume (OR: 1.03,
p Z 0.728). In addition, hospital volume was not signifi-
cantly associated with a decreased relative risk of in-
hospital mortality in comorbid patients with laparoscopic
gastrectomy (OR: 0.66, p Z 0.447).
Table 2 Logistic regression analysis for laparoscopy-
related complications and in-hospital mortality.
OR 95% CI p
Laparoscopy-related complications
Simple logistic regression
LVHs 1.00
HVHs 0.96 (0.79e1.16) 0.684
Multiple logistic regressiona
LVHs 1.00
HVHs 1.03 (0.84e1.27) 0.728
In-hospital mortality
Simple logistic regression
LVHs 1.00
HVHs 0.53 (0.20e1.41) 0.208
Multiple logistic regressiona
LVHs 1.00
HVHs 0.66 (0.23e1.89) 0.447
CI Z confidence interval; HVH Z high-volume hospital;
LVH Z low-volume hospital; OR Z odds ratio.
a OR adjusted for propensity score (level of comorbidity, age,
sex, location of gastric cancer, and type of gastrectomy) and
hospital characteristics (hospital type, size, and region).
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hospital volume and LOS. Multivariate regression analysis
showed that hospital volume was significantly associated
with decreasing LOS in comorbid patients with laparoscopic
gastrectomy. The unstandardized coefficient of HVHs was
4.62 days (p < 0.001). Also, regarding the medical costs
during hospitalization, hospital volume significantly influ-
enced medical costs during hospitalization of comorbid
patients undergoing laparoscopic gastrectomy. The un-
standardized coefficient of HVHs was 1424.1 US dollars
(p < 0.001; Table 3).Table 3 Linear regression analysis for LOS and medical
costs.
Coefficient 95% CI p
LOS (d)
Simple linear regression
LVHs Reference
HVHs 5.84 (6.784.89) <0.001
Multiple linear regressiona
LVHs Reference
HVHs 4.62 (5.633.60) <0.001
Medical costs (US dollars)
Simple linear regression
LVHs Reference
HVHs 1817.9 (2318.01317.9) <0.001
Multiple linear regressiona
LVHs Reference
HVHs 1424.1 (1962.5885.6) <0.001
CI Z confidence interval; HVH Z high-volume hospital;
LOS Z length of stay; LVH Z low-volume hospital.
a Coefficient adjusted for propensity score (level of comor-
bidity, age, sex, location of gastric cancer, and type of gas-
trectomy) and hospital characteristics (hospital type, size, and
region).4. Discussion
Using a national administrative database, we investigated
the influence of hospital volume on outcomes of laparo-
scopic gastrectomy for gastric cancer in patients with co-
morbidity. The current study revealed that hospital volume
was significantly associated with a decrease of LOS and
medical costs of laparoscopic gastrectomy for gastric can-
cer in patients with comorbidity, whereas no association
was observed in laparoscopy-related complications and in-
hospital mortality of patients in Japan.
Although many reports have focused on the efficacy or
safety of laparoscopic gastrectomy for gastric cancer,
studies on the relationship between hospital volume and
outcomes of patients with laparoscopic gastrectomy are
rare. To the best of our knowledge, only one report
describing the relationship between hospital volume
and outcomes of laparoscopic gastrectomy for gastric can-
cer has been published. Kuwabara et al23 investigated the
relationship between hospital volume and outcomes of
laparoscopic gastrectomy for gastric cancer, and concluded
that hospital volume was not associated with the occur-
rence of complications, although operation time was
significantly associated with complications of laparoscopic
gastrectomy in patients with gastric cancer. However, their
report did not focus on the outcomes of comorbid patients
with laparoscopic gastrectomy for gastric cancer. The
World Health Report has highlighted the acceleration of
population aging worldwide, with dramatic increases in the
numbers of elderly people in many countries.24 Increasing
life expectancy and an aging population will inevitably lead
to a growing number of elderly patients with cancer. At the
same time, the number of patients with comorbidity is
rapidly increasing in some developed countries as the
elderly population expands.25,26 Therefore, evaluation of
outcomes in comorbid patients with laparoscopic gastrec-
tomy for gastric cancer is increasingly important because
such information will be essential for targeting future
quality improvement efforts for laparoscopic gastrectomy
for gastric cancer.
This study identified significant associations between
hospital volume and both LOS and medical costs during
hospitalization of comorbid patients with laparoscopic
gastrectomy. Several factors may be associated with
shorter LOS or lower medical costs during hospitalization at
HVHs. Some previous studies have suggested that higher
volume hospitals have many experienced doctors in various
fields of medicine and that specialized teams generally are
present at hospitals with large case volumes and can pro-
vide multidisciplinary care that significantly contributes to
improved clinical outcomes.13e15,27 In addition, many pre-
vious reports have shown that hospitals with larger case
volumes have greater available resources or treatment fa-
cilities for patients.14,28 Also in this study, HVHs contained
more large hospitals, and large hospitals had a shorter LOS
compared with small or medium-sized hospitals. Further-
more, it is reasonable to suppose that medical costs will
decrease with decreasing LOS.29 It is therefore plausible
that hospitals with larger case volumes have shorter LOS
and lower medical costs during hospitalization compared
with lower volume hospitals.
38 A. Murata et al.However, the in-hospital mortality and laparoscopy-
related complications were similar between lower and
higher volume hospitals in our study. Some recent studies
have reported that comorbidity is a predictive risk factor
for laparoscopic complications, and that this surgery for
comorbid patients with gastric cancer should be limited to
healthier patients.30,31 However, several other studies have
suggested that many Japanese surgeons have taken up the
challenge of laparoscopic gastrectomy for gastric cancer,
and that the greater experience of Japanese surgeons and
ongoing technical innovations have resulted in successful
surgical management of laparoscopic gastrectomy.11,32 In
particular, Kodera et al11 have reported that the number of
laparoscopic gastrectomies significantly increased between
the early 1990s and late 2000s in Japan. Therefore, the
widespread application of laparoscopic gastrectomy for
gastric cancer enables the safe treatment of patients with
comorbidity, and may obscure any effect of hospital volume
on the in-hospital mortality and laparoscopy-related com-
plications in comorbid patients in Japan. However, our re-
sults are not necessarily applicable to the USA or some
European countries, where laparoscopic gastrectomy for
gastric cancer has not been frequently performed. To
clarify the effect of hospital volume on outcomes of lapa-
roscopic gastrectomy for gastric cancer in comorbid pa-
tients, further studies from other countries except Japan
may be needed.
The data used represent a major strength of the current
study. One of the benefits of the national database was that
it enabled evaluation of a large number of hospitals in an
unbiased manner, because our investigation involved a
nationally representative sample of patients in a commu-
nity setting.13e16 In 2008, records of 2,120,170 hospitali-
zations were gathered in the administrative database of the
DPC system.33 Therefore, this administrative database also
enables interested parties to evaluate outcomes of indi-
vidual detailed medical treatments, with the validity and
reliability of the data from the DPC database having been
reasonably assured.
The present study had some potential limitations. First,
the data were obtained only from DPC-participating hos-
pitals, so that this administrative database does not include
the data from all hospitals in Japan.10 Therefore, data from
hospitals that do not participate in the DPC should be
analyzed to confirm our findings. Second, because this
administrative database does not include clinical data, such
as staging or histological type of gastric cancer, as well as
operation time or the extent of lymph node dissection, we
could not evaluate the clinical characteristics of the
included patients. Third, we could not investigate the
number or kinds of stapling devices used for laparoscopic
procedures because they were not recorded in the Japa-
nese administrative database. These factors may affect the
outcomes of patients who undergo laparoscopic pro-
cedures, particularly medical costs during hospitalization.9
Fourth, we do not have the data about the number of
surgeons (including experienced surgeons) in participating
hospitals, so we could not investigate the influence of the
ability of the surgeons on outcomes of patients with gastric
cancer. Further clinical studies, including clinical data
about the gastric cancer and devices used for laparoscopic
procedures, as well as the ability of Japanese surgeons, aretherefore needed to evaluate the effects of hospital vol-
ume on outcomes of laparoscopic gastrectomy in patients
with comorbidity.
Despite these limitations, the current study has impli-
cations for health care policy decision making and quality
of patient care. The current study confirmed that hospital
volume significantly influenced LOS and medical costs dur-
ing hospitalization of comorbid patients undergoing lapa-
roscopic gastrectomy for gastric cancer. Therefore, the
centralization of comorbid patients who require laparo-
scopic gastrectomy for gastric cancer could be a quality
improvement initiative in Japan. The current findings pro-
vide good evidence supporting the attempt to steer co-
morbid patients with gastric cancer toward hospitals that
have shorter LOS or lower medical costs during hospitali-
zation. If these health implementations can be performed
in the future, quality of care for gastric cancer will be
maintained while LOS or medical costs during hospitaliza-
tion are lowered in Japan. Further research examining the
association between hospital volume and LOS or medical
costs during hospitalization of comorbid patients might
contribute to changing patient referral policies in Japan. In
addition, consecutive monitoring of outcomes in higher
volume hospitals should also be conducted in the future.
In conclusion, this study demonstrated that hospital
volume was significantly associated with a decrease of LOS
and medical costs of laparoscopic gastrectomy for gastric
cancer in patients with comorbidity in Japan. The current
findings could contribute useful information for future
studies on the quality of patient care in comorbid patients
undergoing laparoscopic gastrectomy for gastric cancer, as
well as for health care policy decision making such as
centralization of patients to higher volume hospitals.
However, no association was observed in the laparoscopy-
related complications and in-hospital mortality of patients
with comorbidity. Further studies may be needed to clarify
the effect of hospital volume for laparoscopy-related
complications and in-hospital mortality of comorbid pa-
tients undergoing laparoscopic gastrectomy for gastric
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